News | September 15, 2021
Fredun Pharma bags Rs 22 crore order from East African countries
The order strengthens the company’s position in the East African market
The order strengthens the company’s position in the East African market
These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients
Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor
Laurus will be incentivised for a portion of its development and commercialisation costs. CHAI will also provide technical and regulatory support to enable accelerated generic development
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
The company plans to enter the formulation business in January 2022. It has also opened a branch in Hyderabad to trade pharmaceutical chemicals
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
First participants enrolled in Phase 1 clinical trial of combination NanoFlu/NVX-CoV2373 vaccine with Matrix-M adjuvant. The Phase 1/2 study will also evaluate immunogenicity and safety
Marketed under the brand name DGJAJ, it helps in the faster recovery of hospitalised patients and reduces supplemental oxygen dependence
The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion
Subscribe To Our Newsletter & Stay Updated
